Related Experiment Video
Updated: Jun 6, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Hematologic and oncologic diseases and the liver.
Marvin M Singh1, Paul J Pockros
1Division of Gastroenterology and Hepatology, Scripps Clinic Torrey Pines, and The Scripps Research Institute, 10666 North Torrey Pines Road, N 203 La Jolla, CA 92037, USA.
This review covers how blood (hematologic) and cancer (oncologic) disorders impact the liver, from mild liver test changes to severe liver failure. It details common nonmalignant and malignant conditions affecting liver function.
Area of Science:
- Hepatology
- Hematology
- Oncology
Background:
- Liver disorders can stem from both malignant and nonmalignant conditions.
- These conditions manifest with a spectrum of symptoms, from minor liver test elevations to fulminant hepatic failure.
- Hematologic and oncologic disorders are significant contributors to liver pathology.
Purpose of the Study:
- To discuss the most common hematologic and oncologic disorders affecting the liver.
- To review the hepatic manifestations of these conditions.
Main Methods:
- Review of nonmalignant hematologic disorders impacting the liver.
- Review of malignant hematologic conditions affecting the liver.
- Discussion of other conditions causing portal hypertension and hepatic metastases.
Main Results:
- Nonmalignant conditions discussed include anemias, paroxysmal nocturnal hemoglobinuria, disseminated intravascular coagulation, malaria, Banti syndrome, porphyrias, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome.
- Malignant hematologic conditions include leukemias, lymphomas, and myeloproliferative disorders.
- Common hepatic manifestations of these disorders are identified.
Conclusions:
- Hematologic and oncologic disorders frequently lead to significant liver involvement.
- Understanding these associations is crucial for diagnosing and managing liver disease in patients with blood and cancer conditions.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
